{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:29:16Z","timestamp":1778797756598,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01590-w","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:02:26Z","timestamp":1728986546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Substantia nigra hyperechogenicity and brain ventricular size as biomarkers of early dementia with Lewy bodies"],"prefix":"10.1186","volume":"16","author":[{"given":"Anna","family":"Planas-Ballv\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Gea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neus","family":"Rabaneda-Lombarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Ispierto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramiro","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Vilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"issue":"4","key":"1590_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44(4):673\u201383.","journal-title":"Psychol Med"},{"issue":"Suppl 1","key":"1590_CR2","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan DB, Fiest KM, Roberts JI, et al. The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review. Can J Neurol Sci J Can Sci Neurol. 2016;43(Suppl 1):S83\u201395.","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"8320901","DOI":"10.1155\/2018\/8320901","volume":"2018","author":"CY Lee","year":"2018","unstructured":"Lee CY, Cheng SJ, Lin HC, Liao YL, Chen PH. Quality of Life in Patients with Dementia with Lewy Bodies. Behav Neurol. 2018;2018:8320901.","journal-title":"Behav Neurol"},{"issue":"1","key":"1590_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JAD-201326","volume":"80","author":"T Rigby","year":"2021","unstructured":"Rigby T, Johnson DK, Taylor A, Galvin JE. Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer\u2019s Disease, and Parkinson\u2019s Disease Dementia. J Alzheimers Dis JAD. 2021;80(1):421\u201332.","journal-title":"J Alzheimers Dis JAD"},{"issue":"1","key":"1590_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"key":"1590_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1017\/S0033291718000995","volume":"49","author":"AJ Thomas","year":"2019","unstructured":"Thomas AJ, Donaghy P, Roberts G, et al. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychol Med. 2019;49:396\u2013402.","journal-title":"Psychol Med"},{"issue":"12","key":"1590_CR7","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.3390\/ijms23126371","volume":"23","author":"O Bousiges","year":"2022","unstructured":"Bousiges O, Blanc F. Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer\u2019s Disease. Int J Mol Sci. 2022;23(12):6371.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1590_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JAD-160322","volume":"54","author":"I van Steenoven","year":"2016","unstructured":"van Steenoven I, Aarsland D, Weintraub D, et al. Cerebrospinal Fluid Alzheimer\u2019s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort. J Alzheimers Dis JAD. 2016;54(1):287\u201395.","journal-title":"J Alzheimers Dis JAD"},{"issue":"2","key":"1590_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, de Beer MH, Teunissen CE, et al. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2017;88(2):113\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1590_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cca.2018.11.027","volume":"490","author":"O Bousiges","year":"2019","unstructured":"Bousiges O, Blanc F. Diagnostic value of cerebro-spinal fluid biomarkers in dementia with lewy bodies. Clin Chim Acta Int J Clin Chem. 2019;490:222\u20138.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"6","key":"1590_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.2009.197483","volume":"81","author":"K Kasuga","year":"2010","unstructured":"Kasuga K, Tokutake T, Ishikawa A, et al. Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2010;81(6):608\u201310.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"1590_CR12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/mds.111","volume":"33","author":"I van Steenoven","year":"2018","unstructured":"van Steenoven I, Majbour NK, Vaikath NN, et al. \u03b1-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies. Mov Disord Off J Mov Disord Soc. 2018;33(11):1724\u201333.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"10","key":"1590_CR13","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","volume":"32","author":"P Eusebi","year":"2017","unstructured":"Eusebi P, Giannandrea D, Biscetti L, et al. Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson\u2019s disease: A systematic review and meta-analysis. Mov Disord Off J Mov Disord Soc. 2017;32(10):1389\u2013400.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"10","key":"1590_CR14","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/acn3.50897","volume":"6","author":"M Bongianni","year":"2019","unstructured":"Bongianni M, Ladogana A, Capaldi S, et al. \u03b1-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann Clin Transl Neurol. 2019;6(10):2120\u20136.","journal-title":"Ann Clin Transl Neurol"},{"key":"1590_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2022.10.007","volume":"104","author":"D Yoo","year":"2022","unstructured":"Yoo D, Bang JI, Ahn C, et al. Diagnostic value of \u03b1-synuclein seeding amplification assays in \u03b1-synucleinopathies: A systematic review and meta-analysis. Parkinsonism Relat Disord. 2022;104:99\u2013109.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1590_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1212\/WNL.45.1.182","volume":"45","author":"G Becker","year":"1995","unstructured":"Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson\u2019s disease visualized by transcranial color-coded real-time sonography. Neurology. 1995;45(1):182\u20134.","journal-title":"Neurology"},{"issue":"11","key":"1590_CR17","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(08)70239-4","volume":"7","author":"D Berg","year":"2008","unstructured":"Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008;7(11):1044\u201355.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1590_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00702-010-0565-6","volume":"118","author":"D Berg","year":"2011","unstructured":"Berg D. Substantia nigra hyperechogenicity is a risk marker of Parkinson\u2019s disease: yes. J Neural Transm (Vienna). 2011;118(4):613\u20139.","journal-title":"J Neural Transm (Vienna)"},{"issue":"14","key":"1590_CR19","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/mds.26055","volume":"29","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Stockner H, Serradell M, et al. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord Off J Mov Disord Soc. 2014;29(14):1774\u201380.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"7","key":"1590_CR20","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00415-015-7745-0","volume":"262","author":"D Vilas","year":"2015","unstructured":"Vilas D, Iranzo A, Pont-Sunyer C, et al. Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression. J Neurol. 2015;262(7):1665\u201372.","journal-title":"J Neurol"},{"issue":"4","key":"1590_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00415-005-0023-9","volume":"253","author":"U Walter","year":"2006","unstructured":"Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinson\u2019s disease with dementia. J Neurol. 2006;253(4):448\u201354.","journal-title":"J Neurol"},{"issue":"8","key":"1590_CR22","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/ene.13028","volume":"23","author":"S Favaretto","year":"2016","unstructured":"Favaretto S, Walter U, Baracchini C, et al. Accuracy of transcranial brain parenchyma sonography in the diagnosis of dementia with Lewy bodies. Eur J Neurol. 2016;23(8):1322\u20138.","journal-title":"Eur J Neurol"},{"issue":"11","key":"1590_CR23","first-page":"1887","volume":"39","author":"D Monaco","year":"2018","unstructured":"Monaco D, Berg D, Thomas A, et al. The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2018;39(11):1887\u201394.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"1590_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.sleep.2019.09.008","volume":"68","author":"M Miyamoto","year":"2020","unstructured":"Miyamoto M, Miyamoto T. Relationship of substantia nigra hyperechogenicity to risk of Lewy body disease in idiopathic REM sleep behavior disorder patients: a longitudinal study. Sleep Med. 2020;68:31\u20134.","journal-title":"Sleep Med"},{"issue":"17","key":"1590_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743\u201355.","journal-title":"Neurology"},{"issue":"9","key":"1590_CR26","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136\u20139.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1590_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"issue":"12","key":"1590_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"20","key":"1590_CR29","first-page":"767","volume":"112","author":"A Lobo","year":"1999","unstructured":"Lobo A, Saz P, Marcos G, et al. Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Med Clin (Barc). 1999;112(20):767\u201374.","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"1590_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"15","key":"1590_CR31","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord Off J Mov Disord Soc. 2008;23(15):2129\u201370.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"4","key":"1590_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/s-0033-1356415","volume":"35","author":"U Walter","year":"2014","unstructured":"Walter U, \u0160koloud\u00edk D. Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med. 2014;35(4):322\u201331.","journal-title":"Ultraschall Med"},{"issue":"2","key":"1590_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/WAD.0000000000000308","volume":"34","author":"LJM Vergouw","year":"2020","unstructured":"Vergouw LJM, Marler LP, van de Berg WDJ, et al. Dementia With Lewy Bodies: A Clinicopathologic Series of False-positive Cases. Alzheimer Dis Assoc Disord. 2020;34(2):178\u201382.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"1590_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s40520-024-02704-y","volume":"36","author":"MI Burgio","year":"2024","unstructured":"Burgio MI, Veronese N, Sar\u00e0 D, et al. Markers for the detection of Lewy body disease versus Alzheimer\u2019s disease in mild cognitive impairment: a systematic review and meta-analysis. Aging Clin Exp Res. 2024;36(1):60.","journal-title":"Aging Clin Exp Res"},{"issue":"12","key":"1590_CR35","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG Mc Keith","year":"2005","unstructured":"Mc Keith IG, Dickson DW, Lowe JM, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863\u201372.","journal-title":"Neurology"},{"issue":"1","key":"1590_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.19052","volume":"13","author":"M Yamada","year":"2020","unstructured":"Yamada M, Komatsu J, Nakamura K, et al. Diagnostic Criteria for Dementia with Lewy Bodies: Updated and Future Directions. J Mov Disord. 2020;13(1):1\u201310.","journal-title":"J Mov Disord"},{"issue":"3","key":"1590_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/mds.20311","volume":"20","author":"D Berg","year":"2005","unstructured":"Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc. 2005;20(3):383\u20135.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"8","key":"1590_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s004150170114","volume":"248","author":"D Berg","year":"2001","unstructured":"Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson\u2019s disease and its relation to clinical findings. J Neurol. 2001;248(8):684\u20139.","journal-title":"J Neurol"},{"issue":"6","key":"1590_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, Roggendorf W, Schr\u00f6der U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol. 2002;59(6):999\u20131005.","journal-title":"Arch Neurol"},{"key":"1590_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fncel.2020.00216","volume":"14","author":"S Zhang","year":"2020","unstructured":"Zhang S, Tao K, Wang J, Duan Y, Wang B, Liu X. Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson\u2019s Disease. Front Cell Neurosci. 2020;14:216.","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"1590_CR41","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/archneur.57.9.1289","volume":"57","author":"D Berg","year":"2000","unstructured":"Berg D, M\u00e4urer M, Warmuth-Metz M, Rieckmann P, Becker G. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch Neurol. 2000;57(9):1289\u201392.","journal-title":"Arch Neurol"},{"issue":"1","key":"1590_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jon19944117","volume":"4","author":"G Becker","year":"1994","unstructured":"Becker G, Bogdahn U, Strassburg HM, et al. Identification of ventricular enlargement and estimation of intracranial pressure by transcranial color-coded real-time sonography. J Neuroimaging Off J Am Soc Neuroimaging. 1994;4(1):17\u201322.","journal-title":"J Neuroimaging Off J Am Soc Neuroimaging"},{"issue":"2","key":"1590_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-190949","volume":"73","author":"AM Crespo-Cuevas","year":"2020","unstructured":"Crespo-Cuevas AM, L\u00f3pez-Cancio E, C\u00e1ceres C, et al. Third Ventricle Width Assessed by Transcranial Sonography as Predictor of Long-Term Cognitive Impairment. J Alzheimers Dis JAD. 2020;73(2):741\u20139.","journal-title":"J Alzheimers Dis JAD"},{"key":"1590_CR44","doi-asserted-by":"publisher","first-page":"20863","DOI":"10.1038\/srep20863","volume":"6","author":"DH Li","year":"2016","unstructured":"Li DH, He YC, Liu J, Chen SD. Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson\u2019s disease: A Systematic Review and Meta-analysis. Sci Rep. 2016;6:20863.","journal-title":"Sci Rep"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01590-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01590-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01590-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T13:10:34Z","timestamp":1729170634000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01590-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01590-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Hospital Universitari Germans Trias i Pujol (PI-18\u2013114). All participants provided informed consent by the Declaration of Helsinki and local clinical research regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}